In a recent cohort study with 319 stage IV MM patients treated with first-line PD-1-based ICI, the presence of any grade IrAEs was significantly associated with longer OS and a higher percentage of patients with IrAEs had disease control compared to those without IrAEs [60]. Here, PDCD1 is linked to Miyoshi myopathy.